Journal
DEVELOPMENTAL CELL
Volume 57, Issue 10, Pages 1241-+Publisher
CELL PRESS
DOI: 10.1016/j.devcel.2022.04.018
Keywords
-
Categories
Funding
- European Research Council (ERC) [ERC-CoG 647057]
- Telethon [GGP20003]
- AIRC [IG 20119]
- Cancer Research UK [A17196, 23982]
Ask authors/readers for more resources
Cell metabolism plays an important role in angiogenesis, as evidenced by the use of glutaminolysis-derived glutamate to produce aspartate. Aspartate activates the mTORC1 pathway, regulating endothelial translation and pyrimidine synthesis.
Angiogenesis, the active formation of new blood vessels from pre-existing ones, is a complex and demanding biological process that plays an important role in physiological as well as pathological settings. Recent evidence supports cell metabolism as a critical regulator of angiogenesis. However, whether and how cell metabolism regulates endothelial growth factor receptor levels and nucleotide synthesis remains elusive. We here shown in both human cell lines and mouse models that during developmental and pathological angiogenesis, endothelial cells (ECs) use glutaminolysis-derived glutamate to produce aspartate (Asp) via aspartate aminotransferase (AST/GOT). Asp leads to mTORC1 activation which, in turn, regulates endothelial translation machinery for VEGFR2 and FGFR1 synthesis. Asp-dependent mTORC1 pathway activation also regulates de novo pyrimidine synthesis in angiogenic ECs. These findings identify glutaminolysis-derived Asp as a regulator of mTORC1-dependent endothelial translation and pyrimidine synthesis. Our studies may help overcome anti-VEGF therapy resistance by targeting endothelial growth factor receptor translation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available